Christopher Drennen v. Fresenius Medical Care Holdings, Inc.

CourtDistrict Court, D. Massachusetts
DecidedMarch 30, 2018
Docket1:09-cv-10179
StatusUnknown

This text of Christopher Drennen v. Fresenius Medical Care Holdings, Inc. (Christopher Drennen v. Fresenius Medical Care Holdings, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Christopher Drennen v. Fresenius Medical Care Holdings, Inc., (D. Mass. 2018).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

CIVIL ACTION NO. 09-10179-GAO

UNITED STATES OF AMERICA, ex rel. CHRISTOPHER DRENNEN, Relator,

v.

FRESENIUS MEDICAL CARE HOLDINGS, INC., d/b/a FRESENIUS MEDICAL CARE NORTH AMERICA, Defendant.

OPINION AND ORDER March 30, 2018

O’TOOLE, D.J. The relator, Christopher Drennen, filed an original complaint under seal in February 2009, asserting violations by the defendant of the False Claims Act, 31 U.S.C. § 3729, et seq. The complaint alleged that Fresenius had billed the federal government for tests that were not reasonable or medically necessary under applicable guidelines. The government moved three times to extend the time within which it could decide whether to elect to intervene in the case as a plaintiff, and the three extensions were granted. However, in granting the third extension, the Court noted that there would be “[n]o further continuances.” (Order Granting United States’ Mot. for Ext. of Time to Intervn. (dkt. no. 19).) Nevertheless, a few months later the government asked for a further extension of time to decide whether to elect to intervene, which the Court denied. The complaint was unsealed in February of 2011, and later amended the following July. On October 2, 2015, more than six and a half years after the relator filed his original complaint and one year after the completion of fact discovery, the government moved to “partially” intervene in “both counts” of the relator’s first amended complaint “to the extent that relator alleges that, between February 10, 2003, and December 31, 2010, defendant Fresenius filed false claims with Medicare for medically unnecessary hepatitis B surface antigen (BsAG) tests.” (United States’ Mot. for Leave to Part. Intervn. 1 (dkt. no. 178).). On March 31, 2017, the Court granted the government’s motion, allowing it to intervene, but added that the government would not be

afforded an opportunity for additional discovery. Two weeks later, the government filed its complaint in intervention, which purported to add new claims to the realtor’s complaint. The newly proposed complaint is the subject of Fresenius’ motion to strike or dismiss. The magistrate judge to whom this case was referred has issued a Report and Recommendation (“R&R”) (dkt. no. 269) recommending that the defendant’s Motion to Strike or Dismiss Portions of the United States’ Complaint in Intervention (dkt. no. 214) be denied. Pending before the Court are Fresenius’ objections to that R&R. Fresenius first objects to the R&R’s recommendation that the government’s newly asserted claims be permitted to survive because they were not expressly precluded by any prior order of this Court.1 Fresenius argues that, as a late intervenor the government may not unilaterally

widen the scope of the litigation at this late stage, but must take the case as it stands. The False Claims Act contemplates government intervention in two circumstances: the government “may elect” to intervene while the relator’s complaint is yet under seal, see 31 U.S.C. § 3730(b), et seq., and a court “may . . . permit” the government to intervene at a later date despite not having previously made a timely election, see id. § 3730(c)(3).2 The statutory language is plain. The former section provides for government intervention as of right at its sole option (“may elect”),

1 The government’s new common law claims for payment by mistake, unjust enrichment, and conversion appear in the government’s complaint in intervention as counts four, five, and six, respectively. (United States’ Compl. 4–5 (dkt. no. 210).) 2 All statutory citations included herein refer to Title 31 of the United State Code. while later intervention after the case has been unsealed requires the court’s permission and a showing of “good cause.” See § 3730(c)(3). Both sections address “intervention,” which is a legal term of art in the context of civil litigation. As such, it invites reference to Rule 24 of the Federal Rules of Civil Procedure and the

body of case law that accompanies it. See Rockwell Int’l Corp. v. United States, 549 U.S. 457, 478 (2007) (referencing general intervention principles in considering intervention under the False Claims Act); United States ex rel. Precision Co. v. Koch Indus., Inc., 31 F.3d 1015, 1017 (10th Cir. 1994) (using Rule 24 to guide analysis of intervention under the False Claims Act); see also United States ex rel. Hall v. Schwartzman, 887 F. Supp. 60, 62 (E.D.N.Y. 1995) (looking to Rule 24 in qui tam case). Rule 24 authorizes both intervention of right, when a court “must permit” a party to intervene in an existing civil action, Fed. R. Civ. P. 24(a), and permissive intervention, when a court “may permit” it under certain circumstances, including when the proposed intervenor “is given a conditional right to intervene by a federal statute.” Fed. R. Civ. P. 24(b)(1)(A). The False

Claims Act is similar. Under § 3730(b)(2), the government has a right, at its election and without the need for judicial permission, to intervene while the complaint filed by the relator remains under seal. Under § 3730(c)(3), after the government has originally elected not to intervene, the court “may nevertheless permit [it] to intervene at a later date upon a showing of good cause.” Intervention under this provision is not of right, but literally permissive. Because of the similarity of the authorities, it is appropriate in considering intervention under § 3730 to take account of relevant guidance from cases decided under Rule 24. Under Rule 24, it is clear that in cases of both permissive intervention and intervention of right “courts have broad authority to limit the ability of the parties to expand the scope of a proceeding beyond the issues litigated by the original parties.” Johnson v. Bd. of Regents, 263 F.3d 1234, 1269 (11th Cir. 2001) (citations omitted). This holds true even when a party intervenes of right. Stringfellow v. Concerned Neighbors in Action, 480 U.S. 370, 383 (1987) (Brennan, J., concurring) (“[R]estrictions on participation may also be placed on an intervenor of right and on

an original party.”) (citing Advisory Committee Notes on Fed. R. Civ. P. 24(a)); Beauregard, Inc. v. Sword Servs., LLC, 107 F.3d 351, 352–53 (5th Cir. 1997) (“[I]t is now a firmly established principle that reasonable conditions may be imposed even upon one who intervenes as of right.”); Newport News Shipbuilding & Drydock Co. v. Peninsula Shipbuilders’ Ass’n, 646 F.2d 117, 122 (4th Cir. 1981) (“Even intervention of right may properly be made conditional by the exigencies of the particular case.”); Shore v. Parklane Hosiery Co., 606 F.2d 354, 356–57 (2d Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Beauregard, Inc. v. Sword Services L L C
107 F.3d 351 (Fifth Circuit, 1997)
Johnson v. Board of Regents of the University of Georgia
263 F.3d 1234 (Eleventh Circuit, 2001)
Stringfellow v. Concerned Neighbors in Action
480 U.S. 370 (Supreme Court, 1987)
Rockwell International Corp. v. United States
549 U.S. 457 (Supreme Court, 2007)
John L. Kelly v. United States
924 F.2d 355 (First Circuit, 1991)
United States Ex Rel. Hall v. Schwartzman
887 F. Supp. 60 (E.D. New York, 1995)
In Re Pharmaceutical Industry Average Wholesale Price Litigation
498 F. Supp. 2d 389 (D. Massachusetts, 2007)
Shore v. Parklane Hosiery Co.
606 F.2d 354 (Second Circuit, 1979)

Cite This Page — Counsel Stack

Bluebook (online)
Christopher Drennen v. Fresenius Medical Care Holdings, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/christopher-drennen-v-fresenius-medical-care-holdings-inc-mad-2018.